Delivery Order SPE2DR25D1202-SPE2DR26F74MR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,373.58 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging. This is a firm fixed-price, competitively awarded contract with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of February 4, 2026. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), is a major...
- The Defense Logistics Agency awarded a delivery order valued at $12,127.84 to AmerisourceBergen Drug Corp for Aprepitant 125 mg capsule unit dose packages (6 count) on February 3, 2026, with completion scheduled for February 4, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $1,792.44 delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules (6-count units) under a firm fixed price contract. This non-set-aside award was issued on December 12, 2025, with an ultimate completion date of December 15, 2025. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,459.88 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (quantity 5) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- This federal contract award was issued by the Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,368.44 firm fixed price delivery order is for the supply of 40 mg Aprepitant capsules, which are a specialty pharmaceutical product used in medical treatment programs and facilities. AmerisourceBergen Drug Corp serves as the prime contractor on an indefinite delivery contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,505.27 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (5 count). The contract, executed on December 17, 2025, with an ultimate completion date of December 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in...
- The Defense Logistics Agency awarded a delivery order valued at $1,756.25 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging. This competitively awarded, firm fixed-price order, which originated under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026), will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order valued at $3,920.19 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging of 5s. This competitive award, executed on April 23, 2025, with an ultimate completion date of April 24, 2025, reflects a firm fixed-price contract type with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on January 5, 2026, for the supply of Aprepitant 40 mg capsules in unit dose packages of 5 units. This is a firm fixed-price delivery order valued at $6,492.22, with an ultimate completion date of January 6, 2026. The work will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Aprepitant 40 mg capsule unit dose packages in quantities of 5. This competitively awarded, non-set-aside contract carries a ceiling value of $10,195.38 and operates under firm fixed pricing terms, with an ultimate completion date of November 4, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F74MRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,152.18 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of five. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at up to $999,999,999.00 through December 2026. The contract specifies performance at the awardee's facility in Conshohocken, Pennsylvania, with completion scheduled for February 5, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical supply chain support to federal agencies, particularly the Defense Health Agency and military healthcare systems worldwide. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical devices across multiple therapeutic domains. No set-aside designation was applied to this award, indicating it was made through full and open competition. This delivery order for Aprepitant, an antiemetic medication commonly used in oncology and healthcare settings, exemplifies the routine pharmaceutical supply operations executed through DLA's pharmaceutical prime vendor contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 2/3/26 |